Plus, Twitter also delivered a beat, Boston Beer cited disappointing demand for its hard seltzer as cause for its earnings results miss, and Alphabet launched a new robotics software startup.
Read MoreBioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is involved in the developing of FixVac product candidates, including BNT111, which is in Phase I clinical trial for advance melanoma; BNT112 that is in Phase I/IIa trial for prostate cancer; BNT113, which is in Phase I/II trial […]
Read MorePlus, Canada said it will allow cruise ships to operate in its waters beginning on November 1, Moderna is joining the S&P 500 next week, and Lordstown Motors confirmed it is being investigated by the Justice Department.
Read MorePlus, Morgan Stanley delivered an earnings beat, Taiwan Semiconductor said it expects sales to rise more than 20% in 2021, and Netflix is pushing into video games with its latest executive hire.
Read MorePlus, Apple asked suppliers to increase iPhone production by 20%, Citigroup delivered an earnings beat, and a short seller accused Oatly of misleading investors and consumers.
Read MorePlus, Pfizer said it is meeting with U.S. health officials today to discuss its COVID-19 vaccine booster shot, Walmart’s Flipkart just completed a $3.6 billion funding round, and grill maker Weber has filed to go public.
Read MoreBuy Price: $235.00 or better Sell Signal: TradersPro Sell Signal Moderna, Inc., a biotechnology company, develops therapeutics and vaccines based on messenger RNA for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases. As of March 9, 2021, the company had 13 programs in clinical trials and a total of 24 […]
Read MorePlus, Wells Fargo said it is shutting down all personal lines of credit to focus more on its credit card and personal loans business, Pfizer plans to apply for emergency use authorization for a booster shot of its COVID-19 vaccine in August, and Stamps.com has agreed to be taken private by Thoma Bravo.
Read MorePlus, jobless claims were higher than expected last week, three dozen state attorneys general filed a new antitrust suit against Google, and Beyond Meat has debuted its new faux-chicken tenders.
Read MoreBuy Price: $13.00 or better Sell Price: TradersPro Sell Signal PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. Its lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment for the recurrent/metastatic head and neck cancer, human papillomavirus associated malignancies, and cervical […]
Read MorePlus, JPMorgan is buying OpenInvest, Walmart will start offering its own brand of analog insulin at a cheaper price for diabetes patients, and Capri Holdings raised its revenue guidance for the year on rising luxury sales.
Read MorePlus, Olive Garden-parent Darden said its same-store sales have nearly returned to pre-pandemic levels, Elon Musk said SpaceX’s Starlink will go public when its cash flow is more predictable, and jobless claims came in above expectations.
Read MoreThere is a lot of fundamental data that I rely on to help paint an overall picture about underlying strength of any stock I might consider using for a value-based investment. While some fundamental investors prefer to work with easy-to-reference, quick-glance data like earnings per share, I prefer to expand my view of a company’s […]
Read MorePlus, GameStop said it raised $1.13 billion through the sale of 5 million additional shares, McDonald’s said it is launching its loyalty program on July 8, and Splunk announced a $1 billion investment from Silver Lake.
Read MoreWith the Nasdaq near all-time highs, one analyst says biotechs will lead the index on its next leg higher. And stocks like these 5 could lead the way.
Read More